Allogeneic T cell progenitors, cultured ex-vivo clinical trials

Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide

This study looks at a new treatment called SMART101 for adults with blood cancers who are having a specific type of stem cell transplant. It aims to see if SMART101 is safe and helps their immune system recover faster after the transplant.